Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Newsflash Previous | All Articles This Week | Next
This article originally posted and appeared in  Issue 569

Lixisenatide Success

Lixisenatide Success

Next possible GLP-1 diabetes drug from Sanofi-Aventis (lixisenatide) has success in a late stage trial, reducing A1c and body weight without increasing risk of hypoglycemi

BYDUREON™ recommended for approval in Europe.

BYDUREON would be first once-weekly treatment for adults with Type 2 diabetes.

Advertisement
Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 14 April, 2011 and appeared in  Issue 569

Past five issues: Diabetes Clinical Mastery Series Issue 219 | Issue 759 | Diabetes Clinical Mastery Series Issue 218 | GLP-1 Special Editions December 2014 | Issue 758 |

2014 Most Popular Articles:

Handbook of Diabetes, 4th Ed., Excerpt #20: Foot Problems in Diabetes
Posted November 29, 2014
Is Type 2 Diabetes an Inflammatory Disease?
Posted November 21, 2014
Handbook of Diabetes, 4th Ed., Excerpt #19: Macrovascular Disease in Diabetes
Posted November 23, 2014
New Guidelines for Doctors to Treat Diabetes
Posted December 12, 2014
Why Are Up to 20% Type 2's Nonresponsive to Exercise?
Posted December 05, 2014
Any Pain Medication Said Effective When Treating Diabetic Nerve Pain
Posted November 21, 2014
New Approach Targets Type 2's Poorly Controlled With Metformin
Posted November 14, 2014
Carbs Associated with Higher Diabetes and Heart Disease Risk Factor
Posted December 05, 2014
Link between Free Fatty Acids and Acute MI, Type 2 Diabetes
Posted November 21, 2014
Knowledge of Onset, Peak, and Duration of Action of Meds Prevents a Trip to the ER
Posted November 24, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
How many of your prediabetic patients have delayed diabetes for more than 5 years with only lifestyle changes?
CME/CE of the Week
Category: Nursing
CE Credits: 1.0



Search Articles On Diabetes In Control